The Daschner Guide To In Hospital Antibiotic Therapy

It fits in every jacket pocket and provides a quick reference guide for all clinically active physicians in hospitals or doctor’s practices. With the nearly unmanageable number of antibiotics an up-to-date, clear-cut presentation is essential. In clear tables – sorted by substances, pathogens and indications – spectra and recommendations for dosages can be easily looked up. Special problems such as the use of antibiotics during pregnancy, in perioperative antibiotic prophylaxis, and for renal and hepatic insufficiency are also included. A guide for your daily work: handy, concise, and clear. Adjusted to European standards: Up-to-date substances, authorizations, resistances and trade names. The first guide to antibiotic therapy for Europe!

Handy – concise – clear The “always on-hand” pocket guide to the treatment of infectious diseases. - The most important antibiotics and antimycotics: Spectrum – dosage – side-effects - Numerous tables sorted by substances, pathogens, indications - Administration of antibiotics during pregnancy, renal and hepatic insufficiency, dialysis - Including statements on the cost of therapy Numerous tips and troubleshooting guides on topics such as: - Potential mistakes - Therapy failures - Perioperative antibiotic prophylaxis Adjusted to European standards: Up-to-date substances, authorizations, resistances and trade names. The first guide to antibiotic therapy for Europe! All in all, an approach that looks towards the future in which antimicrobial resistance will certainly represent an ever-growing obstacle for the medical class, and for which books like this will undoubtedly represent a precious resource. Giuseppe Cornaglia, MD, PhD President, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) This book will most certainly be a valuable asset for all those treating patients with infections. While primarily aimed at the hospital setting, most of the very useful information can certainly be used in other healthcare settings, too. Andreas Voss Professor of Clinical Microbiology and Infection Control Radboud University Nijmegen Medical Centre and Canisius-Wilhelmina Hospital Nijmegen, The Netherlands

The evolution of Antimicrobial Resistance is outpacing the ability to create novel antibiotics, which is proving to be a global problem in the fact of climate change, population growth, demographic shifts toward aging populations, emerging infections, and other crises. Therefore, clinicians are forced to use the existing antimicrobials more responsibly to preserve their longevity for generations to come. In a parallel vein, there has been a recent regulatory acknowledgement of the importance of prudent antimicrobial prescribing, mandating the implementation of Antimicrobial Stewardship across all healthcare settings. This is harder to manage in a non-traditional setting, which include long-term care facilities, outpatient care clinics, urgent care centers, and others. Given the trends in patient care in these settings—particularly where the aging community is concerned—this is proving to be a growing problem. This is troublesome even for spaces that have university and large hospital affiliations. There is a plethora of data describing the implementation and outcomes of Antimicrobial Stewardship Programs in acute-care hospitals with open-access, evidence-based guidelines endorsed by the Infectious Diseases Society of America. However, non-traditional settings often find themselves struggling to implement the same practices and procedures due to their unique needs and limited resources. There may be variability in access to resources, applicability, and patient-type. This book seeks to inform those in non-traditional healthcare settings on the principles, practice, and outcomes of Antimicrobial Stewardship Programs to improve patient care across all settings. The text begins by unpacking Antimicrobial Stewardship in nontraditional settings then covers specific environments, including long-term care facilities, outpatient clinics, and emergency departments. The text also covers special topics, including veterinary medicine, HIV, oncology, and immunocompromised patients, pediatrics, neonates, transplant, and critical care patients.

This leading clinical is reference on treatment of infectious diseases and anti-infective drug information. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, the Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians, the Sanford Guide to Antimicrobial Therapy provides information that is convenient, concise, and reliable. [Ed.]

Antibiotics and Antimicrobial Resistance Genes (AMR) in the Environment summarizes and updates information on antibiotic producing organisms and their resistance and entry routes in soil, air, water and sediment. As antibiotic use continues to rise in healthcare, their fate, bioavailability and biomonitoring, and impacts on environment and public health are becoming increasingly important. The book addresses the impact of antibiotics and AMR to environment and public health and risk assessment. Moreover, it focused on the metagenomics and molecular techniques for the detection of antibiotics and antimicrobial genes. Lastly, it introduces management strategies, such as treatment technologies for managing antibiotics and AMR/ARGs-impacted environment, and bioremediation approaches. Summarizes and updates information on antibiotics and AMR/ARGs production and its fate and transport in the environment Includes phytoremediation and bioremediation technologies for environmental management Provides analysis of risk assessment of antibiotic resistance genes to help understand the environmental and socioeconomic impacts of antibiotics and AMR/ARGs

Antimicrobial resistance (AMR) is one of the deadliest threats to global public health. This book focuses on dynamics in the landscape of AMR while informing about the latest technologies and strategies to mitigate it. The menace of AMR in different niches, routes of penetration across various domains, socio-economic impact, and the need for a 'One Health' approach in mitigating AMR has been emphasized. Factors involved in AMR, underlying mechanisms, and pharmacometrics in developing antimicrobials are highlighted. Emphasis is given to emerging technologies that are sustainable, scalable, and applicable to the global community, such as big data analytics, bioactive agents, phage therapy, and nanotechnology. The book also explores current and alternative treatment strategies to combat AMR, emphasizing the use of nanoparticles to target pathogens and as a viable alternative to antibiotics.